Presence of mutations in all three ras genes in human thyroid tumors
- PMID: 2183158
Presence of mutations in all three ras genes in human thyroid tumors
Abstract
Polymerase chain reaction (PCR) amplification followed by oligonucleotide probing was used to investigate the presence of ras genes mutations in human thyroid adenomas and carcinomas. The results confirm the frequent occurrence of mutations in all three ras genes in both adenomas and carcinomas, in agreement with the hypothesis that the ras mutations may constitute early steps in thyroid tumorigenesis. No evident correlation between the frequency of ras mutations, the identity of the mutated ras gene, the position affected in the ras gene or the type of mutation and the pathological features is apparent. However, definitive conclusion on this point is precluded because of the small number of tumors examined at the present time.
Similar articles
-
Pattern of ras and gsp oncogene mutations in radiation-associated human thyroid tumors.Oncogene. 1995 Aug 3;11(3):601-3. Oncogene. 1995. PMID: 7630645
-
High frequency of ras oncogene activation in all stages of human thyroid tumorigenesis.Oncogene. 1989 Feb;4(2):159-64. Oncogene. 1989. PMID: 2648253
-
Ha-ras oncogene (codon 12) mutation in thyroid carcinogenesis: analysis of 60 benign and malignant thyroid tumors.Ann Biol Clin (Paris). 1995;53(10-11):549-55. Ann Biol Clin (Paris). 1995. PMID: 8787281
-
K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization.Am J Pathol. 1993 Aug;143(2):545-54. Am J Pathol. 1993. PMID: 8342602 Free PMC article. Review.
-
Genetic basis of endocrine disease 3: Molecular defects in thyroid gland neoplasia.J Clin Endocrinol Metab. 1992 Dec;75(6):1398-400. doi: 10.1210/jcem.75.6.1464638. J Clin Endocrinol Metab. 1992. PMID: 1464638 Review. No abstract available.
Cited by
-
UbcH10 overexpression may represent a marker of anaplastic thyroid carcinomas.Br J Cancer. 2005 Aug 22;93(4):464-71. doi: 10.1038/sj.bjc.6602721. Br J Cancer. 2005. PMID: 16106252 Free PMC article.
-
Synthesis and evaluation of antitumor activity of novel N-acyllavendamycin analogues and quinoline-5,8-diones.Bioorg Med Chem. 2007 Jan 1;15(1):495-510. doi: 10.1016/j.bmc.2006.09.039. Epub 2006 Oct 10. Bioorg Med Chem. 2007. PMID: 17035024 Free PMC article.
-
The status of CDKN2A alpha (p16INK4A) and beta (p14ARF) transcripts in thyroid tumour progression.Br J Cancer. 2006 Dec 18;95(12):1670-7. doi: 10.1038/sj.bjc.6603479. Epub 2006 Nov 21. Br J Cancer. 2006. PMID: 17117177 Free PMC article.
-
Molecular biology of thyroid cancer initiation.Clin Transl Oncol. 2007 Nov;9(11):686-93. doi: 10.1007/s12094-007-0125-1. Clin Transl Oncol. 2007. PMID: 18055323 Review.
-
Genetics and epigenetics of sporadic thyroid cancer.Mol Cell Endocrinol. 2014 Apr 5;386(1-2):55-66. doi: 10.1016/j.mce.2013.07.030. Epub 2013 Aug 8. Mol Cell Endocrinol. 2014. PMID: 23933154 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical